Health researchers worldwide can now access the genome data of half a million people enrolled in UK Biobank, the largest number of whole-genome sequences released for medical research. This can help calculate individual risk scores for many diseases and gain insights about serious genetic conditions. Access requires approval and use of a protected database stripped of personal identifiers.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
